The drug development consulting firm Rahaa asks FDA to require stability studies under refrigerated conditions for generic versions of prednisolone op...
FDA gives accelerated approval to Gileads Livdelzi to treat some cases of primary biliary cholangitis.
After reporting preliminary positive results from a Phase 2 clinical trial studying VP-315 in basal cell carcinoma patients, Verrica Pharmaceuticals s...
FDA approves Incytes Niktimvo for some adult and pediatric host-versus-graft treatments.
FDA and the American Society of Clinical Oncology announce a 10/1 joint workshop entitled Measuring Toxicity in Reproductive Organs During Oncology Dr...
FDA clears a Big Health 510(k) for its SleepioRx, a digital therapeutic intended for treating chronic insomnia/insomnia disorder as an adjunct to usua...
Federal Register notice: FDA renews for two years its Peripheral and Central Nervous System Drugs advisory committee.
